New clinical trial results from El Lilly suggest its Type 2 diabetes and weight-loss drug, tirzepatide, could upend the incipient market for MASH treatments.
DuPont’s stock bounced Tuesday, after the parent of Kevlar, Tyvek and Styrofoam brands reported fourth-quarter profit that topped expectations, lifted its.